+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Canine Arthritis Market - Global Forecast 2025-2030- Product Image
Canine Arthritis Market - Global Forecast 2025-2030- Product Image
Sale

Canine Arthritis Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010632
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The canine arthritis market is undergoing rapid transformation as veterinary practices evolve to meet the clinical and economic demands of chronic joint disease management. Senior decision-makers are navigating a complex ecosystem shaped by therapeutic innovation, shifting regulations, and heightened end-user expectations.

Market Snapshot: Canine Arthritis Market Growth & Trends

The canine arthritis market grew from USD 1.92 billion in 2024 to USD 2.08 billion in 2025. It is expected to continue growing at a CAGR of 8.21%, reaching USD 3.09 billion by 2030.

Scope & Segmentation

This report provides detailed analysis and revenue forecasts across major segments, highlighting how evolving clinical needs and stakeholder priorities are reshaping the canine arthritis landscape:

  • Treatment Types: Complementary therapies (nutraceuticals, supplements such as chondroitin, glucosamine, omega fatty acids), non-pharmacological therapies (acupuncture, laser therapy, hydrotherapy, physiotherapy), and pharmacological therapies (disease-modifying agents like hyaluronic acid and polysulfated glycosaminoglycan, monoclonal antibodies such as bedinvetmab, and non-steroidal anti-inflammatory drugs including carprofen, deracoxib, and meloxicam).
  • Drug Classes: Disease-modifying osteoarthritic agents, monoclonal antibodies, and non-steroidal anti-inflammatory drugs—each representing unique efficacy and development pathways.
  • Routes of Administration: Injectable (subcutaneous solutions), oral (tablet/capsule), and topical (gel) formulations tailored for compliance and clinical outcomes.
  • Distribution Channels: Online pharmacies (including general and veterinary-specific ecommerce platforms), pet specialty stores, retail pharmacies, and veterinary hospital pharmacies.
  • End Users: Specialty pet clinics, rehabilitation centers, general and orthopedic veterinary clinics, multispecialty and small animal hospitals.
  • Company Landscape: Strategic analysis includes industry leaders such as Dechra, Elanco, Zoetis, Merck & Co., Vetoquinol, Virbac, Boehringer Ingelheim, Nutramax Laboratories, Colgate-Palmolive, and Nestlé.
  • Regional Analysis:
    • Americas (key markets: US states including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina)
    • Europe, Middle East & Africa (notably UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland)
    • Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)

Key Takeaways for Senior Decision-Makers

  • Market expansion is powered by aging pet populations, increased longevity, and rising demand for improved animal quality of life.
  • Treatment paradigms are shifting towards holistic, multimodal regimens, integrating both established pharmaceuticals and newer biologics.
  • Clinical adoption of advanced digital health tools, remote monitoring, and telehealth is driving personalized care and real-world evidence generation.
  • Owner awareness and willingness to invest in long-term joint health solutions are influencing procurement, product innovation, and overall market direction.
  • Regulatory developments are heightening the need for compliance, especially as agencies introduce stricter post-market surveillance and labeling standards.
  • Collaborations between manufacturers, distributors, clinics, and rehabilitative specialists are accelerating the adoption of multidisciplinary care models, supporting both operational efficiency and improved clinical outcomes.

Tariff Impact: Navigating 2025 U.S. Adjustments

Proposed U.S. tariff adjustments in 2025 are affecting raw material sourcing, pricing strategies, and supply chain transparency. Manufacturers are reassessing acquisition strategies, forming local partnerships, and enhancing inventory controls. Distributors and veterinary pharmacies are renegotiating supplier terms to ensure product stability, while regulatory agencies are increasing documentation requirements—a shift that makes strategic supplier diversification more vital for long-term resilience.

Research Methodology & Data Sources

The report is grounded in robust qualitative and quantitative methodologies, including structured interviews with veterinary practitioners, key opinion leaders, and supply chain executives. Data collection was additionally supported by targeted surveys, peer-reviewed journal reviews, regulatory filings, industry white papers, and validation through multi-source triangulation to assure accuracy and depth.

Why This Report Matters

  • Equips executives with intelligence to optimize product portfolios and supply chain agility in a volatile regulatory environment.
  • Enables precise targeting of regional investments and channel strategies in response to emerging clinical demands.
  • Supports strategic collaboration and technology integration aimed at enhancing animal wellbeing and operational value.

Conclusion

Comprehensive market segmentation, actionable insights, and evidence-based analysis equip senior decision-makers to capitalize on evolving opportunities within the canine arthritis landscape. Stakeholders positioned for innovation and agility will realize sustained growth and improved veterinary health outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for canine stem cell therapies offering regenerative joint repair
5.2. Integration of wearable canine activity monitors to enhance arthritis management outcomes
5.3. Expansion of subscription based joint supplement delivery services targeting senior dogs
5.4. Advancements in canine regenerative platelet rich plasma protocols for osteoarthritis relief
5.5. Regulatory updates accelerating approval pathways for novel canine arthritis therapeutics
5.6. Growth of telemedicine platforms providing remote veterinary arthritis consultations and monitoring
5.7. Adoption of personalized nutrition plans incorporating omega 3 enriched diets for joint support
5.8. Strategic partnerships between pharmaceutical companies and veterinary tech startups to innovate treatment options
5.9. Surge in consumer interest for plant based joint supplements formulated with novel bioactive compounds
5.10. Market expansion in Asia Pacific driven by increasing pet ownership and growing veterinary infrastructure
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Canine Arthritis Market, by Treatment Type
8.1. Introduction
8.2. Complementary Therapies
8.2.1. Nutraceuticals
8.2.2. Supplements
8.2.2.1. Chondroitin
8.2.2.2. Glucosamine
8.2.2.3. Omega Fatty Acids
8.3. Non Pharmacological Therapies
8.3.1. Acupuncture
8.3.2. Laser Therapy
8.3.3. Physical Therapy
8.3.3.1. Hydrotherapy
8.3.3.2. Physiotherapy
8.4. Pharmacological Therapies
8.4.1. Disease Modifying Agents
8.4.1.1. Hyaluronic Acid
8.4.1.2. Polysulfated Glycosaminoglycan
8.4.2. Monoclonal Antibodies
8.4.2.1. Bedinvetmab
8.4.3. Non Steroidal Anti Inflammatory Drugs
8.4.3.1. Carprofen
8.4.3.2. Deracoxib
8.4.3.3. Meloxicam
9. Canine Arthritis Market, by Drug Class
9.1. Introduction
9.2. Disease Modifying Osteoarthritic Agents
9.2.1. Hyaluronic Acid
9.2.2. Polysulfated Glycosaminoglycan
9.3. Monoclonal Antibodies
9.3.1. Bedinvetmab
9.4. Non Steroidal Anti Inflammatory Drugs
9.4.1. Carprofen
9.4.2. Deracoxib
9.4.3. Meloxicam
10. Canine Arthritis Market, by Route Of Administration
10.1. Introduction
10.2. Injectable
10.2.1. Subcutaneous
10.3. Oral
10.3.1. Tablet Capsule
10.4. Topical
10.4.1. Gel
11. Canine Arthritis Market, by Distribution Channel
11.1. Introduction
11.2. Online Pharmacies
11.2.1. General E Commerce Platforms
11.2.2. Vet E Commerce Platforms
11.3. Pet Specialty Stores
11.4. Retail Pharmacies
11.5. Veterinary Hospital Pharmacies
12. Canine Arthritis Market, by End User
12.1. Introduction
12.2. Specialty Pet Clinics
12.2.1. Rehabilitation Centers
12.3. Veterinary Clinics
12.3.1. General Practice Clinics
12.3.2. Orthopedic Clinics
12.4. Veterinary Hospitals
12.4.1. Multispecialty Hospitals
12.4.2. Small Animal Hospitals
13. Canine Arthritis Market, by Company
13.1. Introduction
13.2. Dechra
13.3. Elanco
13.4. Zoetis
14. Americas Canine Arthritis Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Canine Arthritis Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Canine Arthritis Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Zoetis Inc.
17.3.2. Elanco Animal Health Incorporated
17.3.3. Merck & Co., Inc.
17.3.4. Dechra Pharmaceuticals PLC
17.3.5. Vetoquinol SA
17.3.6. Virbac SA
17.3.7. Boehringer Ingelheim International GmbH
17.3.8. Nutramax Laboratories, Inc.
17.3.9. Colgate-Palmolive Company
17.3.10. Nestlé S.A.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CANINE ARTHRITIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CANINE ARTHRITIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CANINE ARTHRITIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CANINE ARTHRITIS MARKET: RESEARCHAI
FIGURE 28. CANINE ARTHRITIS MARKET: RESEARCHSTATISTICS
FIGURE 29. CANINE ARTHRITIS MARKET: RESEARCHCONTACTS
FIGURE 30. CANINE ARTHRITIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CANINE ARTHRITIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CHONDROITIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CHONDROITIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GLUCOSAMINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GLUCOSAMINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OMEGA FATTY ACIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OMEGA FATTY ACIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY LASER THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYDROTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYDROTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY POLYSULFATED GLYCOSAMINOGLYCAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY POLYSULFATED GLYCOSAMINOGLYCAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY BEDINVETMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY BEDINVETMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CARPROFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CARPROFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DERACOXIB, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DERACOXIB, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MELOXICAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MELOXICAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY POLYSULFATED GLYCOSAMINOGLYCAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY POLYSULFATED GLYCOSAMINOGLYCAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY BEDINVETMAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY BEDINVETMAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CARPROFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CARPROFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DERACOXIB, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DERACOXIB, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MELOXICAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MELOXICAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TABLET CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TABLET CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GENERAL E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GENERAL E COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VET E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VET E COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GENERAL PRACTICE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GENERAL PRACTICE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MULTISPECIALTY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MULTISPECIALTY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SMALL ANIMAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SMALL ANIMAL HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DECHRA, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DECHRA, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ELANCO, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ELANCO, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ZOETIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ZOETIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 263. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 264. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 265. CANADA CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. CANADA CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. CANADA CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 268. CANADA CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 269. CANADA CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 270. CANADA CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 271. CANADA CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 272. CANADA CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 273. CANADA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 274. CANADA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 275. CANADA CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 276. CANADA CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 277. CANADA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2024 (USD MILLION)
TABLE 278. CANADA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2025-2030 (USD MILLION)
TABLE 279. CANADA CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 280. CANADA CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 281. CANADA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 282. CANADA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 283. CANADA CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 284. CANADA CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 285. CANADA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2024 (USD MILLION)
TABLE 286. CANADA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2025-2030 (USD MILLION)
TABLE 287. CANADA CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 288. CANADA CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 289. CANADA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 290. CANADA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 291. CANADA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. CANADA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. CANADA CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 294. CANADA CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 295. CANADA CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 296. CANADA CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 297. CANADA CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 298. CANADA CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 299. CANADA CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. CANADA CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. CANADA CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 302. CANADA CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 303. CANADA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. CANADA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. CANADA CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2024 (USD MILLION)
TABLE 306. CANADA CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2025-2030 (USD MILLION)
TABLE 307. CANADA CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 308. CANADA CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 309. CANADA CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 310. CANADA CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 311. CANADA CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2024 (USD MILLION)
TABLE 312. CANADA CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2025-2030 (USD MILLION)
TABLE 313. MEXICO CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 314. MEXICO CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 315. MEXICO CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2024 (USD MILLION)
TABLE 316. MEXICO CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2025-2030 (USD MILLION)
TABLE 317. MEXICO CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 318. MEXICO CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 319. MEXICO CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 320. MEXICO CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 321. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 322. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 323. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2024 (USD MILLION)
TABLE 324. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2025-2030 (USD MILLION)
TABLE 325. MEXICO CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2024 (USD MILLION)
TABLE 326. MEXICO CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2025-2030 (USD MILLION)
TABLE 327. MEXICO CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 328. MEXICO CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 329. MEXICO CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2024 (USD MI

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Canine Arthritis market report include:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Dechra Pharmaceuticals PLC
  • Vetoquinol SA
  • Virbac SA
  • Boehringer Ingelheim International GmbH
  • Nutramax Laboratories, Inc.
  • Colgate-Palmolive Company
  • Nestlé S.A.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.09 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Canine Arthritis Treatment - Global Strategic Business Report - Product Image

Canine Arthritis Treatment - Global Strategic Business Report

  • Report
  • 214 Pages
  • Global
From
Canine Arthritis Treatment Market 2025-2029 - Product Image

Canine Arthritis Treatment Market 2025-2029

  • Report
  • 215 Pages
  • Global
From
Canine Arthritis Treatment Global Market Report 2025 - Product Image

Canine Arthritis Treatment Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Drug Therapy for Infectious Diseases of the Dog and Cat. Edition No. 1 - Product Image

Drug Therapy for Infectious Diseases of the Dog and Cat. Edition No. 1

  • Book
  • 328 Pages
Canine Vaccine Market - Global Forecast 2025-2030 - Product Image

Canine Vaccine Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From

About the Canine Arthritis Drugs Market

The Canine Arthritis Drugs market is a segment of the Animal Pharmaceuticals industry that focuses on providing medications to treat arthritis in dogs. These drugs are typically used to reduce inflammation and pain, as well as to slow the progression of the disease. Commonly used drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs). In addition, supplements such as glucosamine and chondroitin are often used to help manage the symptoms of arthritis. The Canine Arthritis Drugs market is highly competitive, with a number of companies offering products to treat the condition. Some of the major players in the market include Zoetis, Elanco, Merck Animal Health, Bayer Animal Health, and Ceva Animal Health. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.